Biopsy transcriptome expression profiling: proper validation is key - Authors' reply

Affiliations

¹ Renal Unit, University of Sydney at Westmead Hospital, Sydney, NSW, Australia.
² Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
³ Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
⁴ Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: barbara.murphy@mountsinai.org.

Comment

Philip J O'Connell et al. Lancet. 2017.

. 2017 Feb 11;389(10069):601.

doi: 10.1016/S0140-6736(17)30283-0.

¹ Renal Unit, University of Sydney at Westmead Hospital, Sydney, NSW, Australia.
² Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
³ Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
⁴ Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: barbara.murphy@mountsinai.org.

No abstract available

Comment on

Biopsy transcriptome expression profiling: proper validation is key.
Reeve J, Halloran PF. Reeve J, et al. Lancet. 2017 Feb 11;389(10069):600-601. doi: 10.1016/S0140-6736(17)30282-9. Lancet. 2017. PMID: 28195055 No abstract available.